(Q36822388)

16 August 2017

1 reference

title

Oral anticancer drugs in the elderly: an overview (English)

1 reference

16 August 2017

Sara Lonardi

1

0 references

Silvio Monfardini

object named as

Silvio Monfardini

series ordinal

4

0 references

author name string

Alberto Bortolami

series ordinal

2

1 reference

PubMed ID

17503896

16 August 2017

Micaela Stefani

series ordinal

3

1 reference

16 August 2017

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

24

1 reference

16 August 2017

395-410

1 reference

16 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200724050-00004

16 August 2017

0 references

cites work

Factors affecting drug binding in plasma of elderly patients

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200724050-00004

Drug-induced illness as a cause for admission to a community hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200724050-00004

Patient compliance with prolonged low-dose oral etoposide for small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200724050-00004

Capecitabine-induced potentiation of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200724050-00004

Unexpected toxicities in elderly patients treated with oral idarubicin in metastatic breast cancer: the GINECO experience

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200724050-00004

Practical management of patients with chronic myeloid leukemia receiving imatinib

21 January 2018

1 reference

12 December 2020

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer

1 reference

12 December 2020

Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women

1 reference

12 December 2020

1 reference

12 December 2020

Drug interactions with cancer chemotherapy

1 reference

12 December 2020

Pharmacokinetic considerations of oral chemotherapy in elderly patients with cancer

1 reference

12 December 2020

A comprehensive geriatric assessment (CGA) is necessary for the study and the management of cancer in the elderly

1 reference

12 December 2020

Antineoplastic chemotherapy of the older cancer patient

1 reference

12 December 2020

Oral topoisomerase 1 inhibitors in adult patients: present and future

1 reference

12 December 2020

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study

1 reference

12 December 2020

Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors

1 reference

12 December 2020

Non-small-cell lung cancer in elderly patients: influence of age on vinorelbine oral pharmacokinetics

1 reference

12 December 2020

The use of temozolomide in recurrent malignant gliomas

1 reference

12 December 2020

Patient selection for oral chemotherapy.

1 reference

12 December 2020

Oral idarubicin and cyclophosphamide for metastatic breast cancer in elderly patients

1 reference

12 December 2020

Patient preferences for oral versus intravenous palliative chemotherapy

1 reference

12 December 2020

Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.

1 reference

12 December 2020

Safety profile of gefitinib in advanced non-small cell lung cancer elderly patients with chronic renal failure: two clinical cases

1 reference

12 December 2020

A multicenter randomized phase II study of oral vs. intravenous vinorelbine in advanced non-small-cell lung cancer patients.

1 reference

12 December 2020

Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients

1 reference

12 December 2020

A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer

1 reference

12 December 2020

Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

12 December 2020

Oral chemotherapy: rationale and future directions

1 reference

12 December 2020

A prospective study on glioblastoma in the elderly

1 reference

12 December 2020

Phase II study of oral idarubicin in elderly patients with advanced breast cancer.

1 reference

12 December 2020

1 reference

12 December 2020

UFT plus or minus calcium folinate for metastatic colorectal cancer in older patients

1 reference

12 December 2020

Health of the elderly and use of health services

1 reference

12 December 2020

Cancer treatment and age: patient perspectives

1 reference

12 December 2020

Safe Administration of Oral Chemotherapy

1 reference

12 December 2020

Pharmacological analysis of etoposide in elderly patients with lung cancer

1 reference

12 December 2020

Medication compliance as a feature in drug development

1 reference

12 December 2020

Polypharmacy: the cure becomes the disease

1 reference

12 December 2020

Phase II single-agent studies in elderly cancer patients

1 reference

12 December 2020

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study

1 reference

12 December 2020

The use of oral cytotoxic and cytostatic drugs in cancer treatment

1 reference

12 December 2020

Uracil and tegafur modulated with leucovorin: an effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly. Oncopaz Cooperative Group.

1 reference

12 December 2020

Clinical pharmacokinetics of capecitabine

1 reference

12 December 2020

Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels

1 reference

12 December 2020

Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions

1 reference

12 December 2020

Potential role of oral anthracyclines in older patients with cancer

1 reference

12 December 2020

Individualized drug use assessment in the elderly

1 reference

12 December 2020

Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites

1 reference

12 December 2020

Cancer in the elderly: why so badly treated?

1 reference

12 December 2020

Cancer pharmacology in the elderly.

1 reference

12 December 2020

Phase II study of an 'all-oral' regimen of capecitabine, idarubicin and cyclophosphamide for metastatic breast cancer--safety, efficacy and quality of life

1 reference

12 December 2020

Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC).

1 reference

12 December 2020

Oral chemotherapy for colorectal cancer: some economic considerations

1 reference

12 December 2020

Oral idarubicin as single-agent treatment of acute nonlymphocytic leukemia in poor-risk patients

1 reference

12 December 2020

Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B

1 reference

12 December 2020

Underrepresentation of patients 65 years of age or older in cancer-treatment trials

1 reference

12 December 2020

Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party.

1 reference

12 December 2020

Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy.

1 reference

12 December 2020

Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99).

1 reference

12 December 2020

Effects of aging on the renal glomerulus

1 reference

12 December 2020

Polypharmacy in the Older Patient With Cancer

1 reference

12 December 2020

Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery.

1 reference

12 December 2020

Enhancing patient compliance in the elderly. Role of packaging aids and monitoring

1 reference

12 December 2020

Imatinib mesylate: in the treatment of gastrointestinal stromal tumours

1 reference

12 December 2020

Low-dose oral fludarabine plus cyclophosphamide in elderly patients with chronic lymphoproliferative disorders

1 reference

12 December 2020

Totally implantable venous access ports systems for patients receiving chemotherapy for solid tissue malignancies: A randomized controlled clinical trial examining the safety, efficacy, costs, and impact on quality of life.

1 reference

12 December 2020

A prospective randomized trial of doxorubicinversus idarubicin in the treatment of advanced breast cancer

1 reference

12 December 2020

Pharmacology of cancer chemotherapy in the older person.

1 reference

12 December 2020

Nursing strategies for patients on oral chemotherapy

1 reference

12 December 2020

Patient noncompliance with self-administered chemotherapy

1 reference

12 December 2020

Estimating creatinine clearance in elderly patients with low serum creatinine concentrations.

1 reference

12 December 2020

The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly.

1 reference

12 December 2020

Oral 5-fluorouracil in squamous cell carcinoma of the skin in the aged.

1 reference

12 December 2020

Pharmacokinetic drug interactions with anticancer drugs.

1 reference

12 December 2020

Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies

1 reference

12 December 2020

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

1 reference

12 December 2020

Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study.

1 reference

12 December 2020

Patient compliance with oral chemotherapy as assessed by a novel electronic technique

1 reference

12 December 2020

Compliance with oral drug therapy in patients with hematologic malignancy.

1 reference

12 December 2020

Effects of Vinorelbine on Quality of Life and Survival of Elderly Patients With Advanced Non-Small-Cell Lung Cancer

1 reference

12 December 2020

Should elderly cancer patients be entered in dose-escalation studies?

1 reference

12 December 2020

Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicity

1 reference

12 December 2020

Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients.

1 reference

12 December 2020

The impact of cancer on the physical function of the elderly and their utilization of health care

1 reference

12 December 2020

Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience

1 reference

12 December 2020

Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients

1 reference

12 December 2020

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

1 reference

12 December 2020

Validation of a multidimensional evaluation scale for use in elderly cancer patients

1 reference

12 December 2020

Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II study

1 reference

12 December 2020

Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).

1 reference

12 December 2020

Evaluation of renal function in elderly cancer patients

1 reference

12 December 2020

Capecitabine as first-line treatment for patients older than 70 years with metastatic colorectal cancer: an oncopaz cooperative group study

1 reference

12 December 2020

Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer

1 reference

12 December 2020

Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108.

1 reference

12 December 2020

A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients

1 reference

12 December 2020

Oral cancer chemotherapy: the promise and the pitfalls

1 reference

12 December 2020

Pharmacology and organ toxicity of chemotherapy in older patients

1 reference

12 December 2020

10.2165/00002512-200724050-00004

Identifiers

DOI

1 reference

PubMed ID

17503896

Dimensions Publication ID

16 August 2017

0 references

1 reference

PubMed ID

17503896